{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:55:18Z","timestamp":1791348918276,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK105821"],"award-info":[{"award-number":["R01 DK105821"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK076077"],"award-info":[{"award-number":["DK076077"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK087635"],"award-info":[{"award-number":["DK087635"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP3 DK108220"],"award-info":[{"award-number":["DP3 DK108220"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2-CX001780"],"award-info":[{"award-number":["IK2-CX001780"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["GM109145"],"award-info":[{"award-number":["GM109145"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["GM131770"],"award-info":[{"award-number":["GM131770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 GM120523"],"award-info":[{"award-number":["R01 GM120523"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 GM007569"],"award-info":[{"award-number":["T32 GM007569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BioVU","award":["R01 LM010685"],"award-info":[{"award-number":["R01 LM010685"]}]},{"name":"BioVU","award":["P50-GM115305"],"award-info":[{"award-number":["P50-GM115305"]}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1-RR024975"],"award-info":[{"award-number":["UL1-RR024975"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1-TR000445"],"award-info":[{"award-number":["UL1-TR000445"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.kint.2020.01.027","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T11:28:17Z","timestamp":1581938897000},"page":"1032-1041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways"],"prefix":"10.1016","volume":"97","author":[{"given":"Archna","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ihegword","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxiang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeron M.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bastarache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QiPing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Kember","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Risman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy D.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Birtwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regeneron Genetics","family":"Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Damrauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Susztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2020.01.027_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0272-6386(88)80221-X","article-title":"Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension","volume":"12","author":"McClellan","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2020.01.027_bib2","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1056\/NEJM198910193211603","article-title":"Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes","volume":"321","author":"Cowie","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.01.027_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048407","article-title":"Incidence and predictors of end stage renal disease among low-income blacks and whites","volume":"7","author":"Lipworth","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2020.01.027_bib4","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1681\/ASN.2016111262","article-title":"Identifying the intracellular function of APOL1","volume":"28","author":"Bruggeman","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib5","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170647","article-title":"Transcription and translation of APOL1 variants","volume":"37","author":"Ejaz","year":"2017","journal-title":"Biosci Rep"},{"key":"10.1016\/j.kint.2020.01.027_bib6","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease","volume":"22","author":"Madhavan","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"P\u00e9rez-Morga","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.kint.2020.01.027_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.molmed.2018.05.008","article-title":"APOL1: the balance imposed by infection, selection, and kidney disease","volume":"24","author":"Beckerman","year":"2018","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.kint.2020.01.027_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.kint.2020.01.027_bib10","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib11","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.2014.254","article-title":"for the SPRINT Investigators. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial","volume":"87","author":"Langefeld","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.01.027_bib13","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"for the CRIC Study Investigators. APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.01.027_bib14","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1681\/ASN.2015070763","article-title":"Race, APOL1 Risk, and eGFR Decline in the General Population","volume":"27","author":"Grams","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib15","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2010121234","article-title":"Genetic variation in APOL1 associates with younger age at hemodialysis initiation","volume":"22","author":"Kanji","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib16","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib17","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib18","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jacc.2017.01.040","article-title":"Apolipoprotein L1 variants and blood pressure traits in African Americans","volume":"69","author":"Nadkarni","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2020.01.027_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCRESAHA.114.302347","article-title":"Increased burden of cardiovascular disease in carriers of APOL1 genetic variants","volume":"114","author":"Ito","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2020.01.027_bib20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/ATVBAHA.115.305970","article-title":"APOL1 genotype, kidney and cardiovascular disease, and death in older adults","volume":"36","author":"Mukamal","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2020.01.027_bib21","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/ATVBAHA.117.309384","article-title":"APOL1 risk variants and cardiovascular disease: results from the AASK (African American Study of Kidney Disease and Hypertension)","volume":"37","author":"Chen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2020.01.027_bib22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nbt.2749","article-title":"Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data","volume":"31","author":"Denny","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.kint.2020.01.027_bib23","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/bioinformatics\/btu197","article-title":"R\u00a0PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment","volume":"30","author":"Carroll","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.kint.2020.01.027_bib24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1681\/ASN.2015020124","article-title":"APOL1 genotype and race differences in incident albuminuria and renal function decline","volume":"27","author":"Peralta","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.4287","article-title":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2020.01.027_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/modpathol.2014.92","article-title":"Histopathologic findings associated with APOL1 risk variants in chronic kidney disease","volume":"28","author":"Larsen","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2020.01.027_bib27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2215\/CJN.01180117","article-title":"APOL1 risk variants, incident proteinuria, and subsequent eGFR decline in blacks with hypertension-attributed CKD","volume":"12","author":"Chen","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14797\/mdcj-12-4s1-2","article-title":"The apolipoprotein L1 gene and cardiovascular disease","volume":"12","author":"Robinson","year":"2016","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.kint.2020.01.027_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.semnephrol.2017.07.005","article-title":"The expanding role of APOL1 risk in chronic kidney disease and cardiovascular disease","volume":"37","author":"Estrella","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib30","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1681\/ASN.2019030240","article-title":"APOL1 kidney risk variants and cardiovascular disease: an individual participant data meta-analysis","volume":"30","author":"Grams","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.118.036589","article-title":"for the VA Million Veteran Program. Association of APOL1 risk alleles with cardiovascular disease in blacks in the Million Veteran Program","volume":"140","author":"Bick","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2020.01.027_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.01.027_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/clpt.2008.89","article-title":"Development of a large-scale de-identified DNA biobank to enable personalized medicine","volume":"84","author":"Roden","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.kint.2020.01.027_bib34","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods","volume":"48","author":"Das","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2020.01.027_bib35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/bioinformatics\/btu704","article-title":"minimac2: faster genotype imputation","volume":"31","author":"Fuchsberger","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.kint.2020.01.027_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg0119s68","article-title":"Quality control procedures for genome-wide association studies","author":"Turner","year":"2011","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.kint.2020.01.027_bib37","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/bioinformatics\/btx186","article-title":"StrandScript: evaluation of Illumina genotyping array design and strand correction","volume":"33","author":"Wang","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.kint.2020.01.027_bib38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrneph.2013.34","article-title":"APOL1 variants and kidney disease in people of recent African ancestry","volume":"9","author":"Genovese","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2020.01.027_bib39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"for the CKD-EPI. A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kint.2020.01.027_bib40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/bioinformatics\/btq126","article-title":"PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations","volume":"26","author":"Denny","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.kint.2020.01.027_bib41","first-page":"15","article-title":"That BLUP is a good thing: the estimation of random effects","volume":"6","author":"Robinson","year":"1991","journal-title":"Stat Sci"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820301411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820301411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:55:41Z","timestamp":1758761741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253820301411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0085253820301411"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2020.01.027","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2020.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}